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Tear Film Osmolarity in Response to Long-Term
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Purpose: To compare tear ﬁlm osmolarity (TFO) measurements in non–
contact lens (CL) wearers and wearers of hydrogel or overnight orthoker-
atology (OK) CLs, and to assess possible effects of long-term OK on TFO.
Methods: Overall, 108 subjects with moderate myopia participated in 2
experiments, and TFO was measured using the TearLab osmolarity system.
In experiment 1, TFO measurements were made in 77 right eyes of 23 non-
CL wearers, 26 hydrogel wearers, and 28 OK wearers. Subjects in the last 2
groups had worn their CL for at least 3 years. In experiment 2, 31
individuals (habitual soft CL wearers) were enrolled for prospective long-
term follow-up of OK treatment. These subjects were ﬁtted with Paragon-
CRT (n¼16) or Seefree (n¼15) lenses, and TFO readings were taken at
baseline and after 1 month and 1 year of lens wear and after 1 month of OK
treatment interruption.
Results: Values of TFO were within the normal limits in all 3 subject
groups, although signiﬁcantly lower osmolarities (P,0.01) were observed
in non-CL wearers (281.765.9 mOsm/L) compared with hydrogel
(291616.5 mOsm/L) or OK lens wearers (301.7610.8 mOsm/L). In exper-
iment 2, TFO differed signiﬁcantly at baseline between the Paragon-CRT
and Seefree groups (P,0.05), and a signiﬁcant decrease in TFO compared
with baseline (P,0.01) was observed in the Paragon-CRT group after 1
month of cessation of lens wear.
Conclusion: Higher TFO values were observed in lens wearers (hydrogel
or OK) than non-CL wearers. After interruption of OK treatment, TFO
returned to similar values to those found in non-CL wearers.
Key Words: Tear ﬁlm osmolarity—Overnight orthokeratology—Contact
lenses—TearLab osmolarity system.
(Eye & Contact Lens 2016;0: 1–6)
O rthokeratology (OK), also known as overnight cornealrefractive therapy or corneal reshaping, is a clinical tech-
nique designed to transiently reduce or eliminate myopia. Over the
years, developments in the ﬁeld have made OK a feasible correction
option for subjects who prefer not to wear spectacles or contact
lenses (CLs) during the day. Today’s ﬁtting techniques enable
predictable and safe outcomes for improving uncorrected visual
acuity and contrast sensitivity,1–4 including satisfactory subjective
vision according to the National Eye Institute Refractive Error
Quality of Life Instrument-42 questionnaire.5
The success of OK has been accompanied by a need to address the
corneal response to treatment. Recent research efforts have examined
changes in corneal morphology and physiology by assessing the
effects of treatment on cell density,6–8 thicknesses of the corneal
layers,9–11 subbasal nerve plexus (SBNP) distribution,7,12 and cor-
neal biomechanics.13–15 Some studies have also determined OK
effects on tear ﬁlm components,16 such as inﬂammatory mediators.17
These studies conducted both in animals18–20 and humans6,7,12 have
identiﬁed corneal changes produced in stromal and epithelial cell
density, SBNP thickness and distribution,7,12 and epithelial layer
thickness ans also changes in the levels and distribution of proin-
ﬂammatory mediators in the tear ﬁlm samples of OK wearers.17,21
To date, however, the effects of OK treatment on tear ﬁlm osmolarity
(TFO) have not yet been examined. Some authors have reported that
TFO increases are associated with CL wear.22,23 As suggested by
Efron et al,24 CL wear may increase osmolarity in two ways: (1) by
inducing tear ﬁlm evaporation and (2) by inducing electrolyte con-
centration changes. The cycle of events leading to elevated TFO has
been described as a closed loop in a report by the Dry Eye Workshop
(DEWS).25 According to this theory, hyperosmolarity causes dam-
age to the corneal epithelial surface by activating a cascade of
inﬂammatory events on the ocular surface, including the release
of inﬂammatory mediators into the tears, which could be a cause
of nerve injury and/or raised TFO.
This study was designed to examine the TFO response to OK
wear. In a ﬁrst experiment, we compared TFO in OK and hydrogel
CL wearers versus non-CL wearers, and then in experiment 2, we
examined TFO changes produced in response to long-term OK
treatment. We also determined whether these changes were
reversible after treatment cessation.
MATERIAL AND METHODS
The study was conducted by the Contactology and Optometry
Research Group, Complutense University of Madrid (Spain). The
study protocol adhered to the tenets of the Declaration of Helsinki and
was approved by the Ethics Committee of the Hospital San Carlos
(Madrid, Spain). Participants gave their written informed consent.
Study Design
The study was designed as two experiments. The ﬁrst (exper-
iment 1) was a case/control study comparing TFO data in non-CL
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wearers and long-term wearers ($3 years) of two CL types. For
these measurements, 77 right eyes of 77 subjects were divided into
3 groups: (1) non-CL wearers, (2) hydrogel lens wearers, and (3)
OK lens wearers. Experiment 2 was a prospective, longitudinal,
single-center study designed to assess the TFO response to OK
wear over time (13 months). In this experiment, TFO measure-
ments were made in 31 right eyes of 31 individuals (habitual soft
CL wearers) undergoing overnight OK for the ﬁrst time. Measure-
ments of TFO were then compared for baseline, 1 month and 1 year
after starting OK treatment, and 1 month after OK treatment ces-
sation. The subjects were assigned to two groups matched for age,
refractive state, and corneal curvature and ﬁtted with two OK lens
designs (Seefree or Paragon-CRT).
Tear ﬁlm osmolarity was measured using the TearLab system
(TearLab Corp, San Diego, CA). We calculated sample sizes from
published normality data (means, standard deviations, and coefﬁ-
cients of repeatability).25 For a signiﬁcance (alpha) of 0.05 for a type
I error and beta of 0.2 for a type II error in a 2-tailed test, the number
of subjects needed for each group in experiment 1 was calculated as
21 to detect a difference greater than the standard deviation (assumed
as 9 units or mOsm/L). For the second experiment, it was calculated
that 15 subjects per treatment group would be needed to detect
a signiﬁcant difference greater than 9 units assuming the same cri-
teria as for the above calculations and a correlation coefﬁcient
between the initial and ﬁnal measurement of 0.75.
Participants
All subjects enrolled were subjected to a full eye examination.
Inclusion criteria for both groups of participants were as follows:
age, 18 to 30 years; 20.50 to 25.00 diopters (D) of sphere, 20.25
to21.25 D of cylinder, and monocular best-corrected visual acuity
(BCVA) of at least 0.04 logarithm of the minimum angle of reso-
lution (logMAR). The baseline refractive state of each participant
was measured as manifest refraction using a phoropter at the study
outset.
Subjects were excluded if they had used gas permeable CL in the
past. In experiment 1, hydrogel and OK lens wearers continued
using their CL as normal. In experiment 2, participants were
instructed to stop wearing their soft CLs 4 weeks before the study
start.
Subjects were also excluded if they were pregnant or planning to
become pregnant over the following 12 months. Individuals who
experienced any systemic or eye disease including dry eye
syndrome (DES) were also excluded because this could affect
TFO. Following the DEWS25 recommendations, both symptom
questionnaires and objective clinical measures were used as diag-
nostic criteria of DES. These tests were ﬂuorescein breakup time
(FBUT) for tear ﬁlm stability,26 the phenol red test (PRT) for tear
secretion,27 and McMonnies questionnaire28 for ocular symptoms
and their severity. The cutoffs used for DES were FBUT of ,10
seconds, PRT of ,18 mm, and McMonnies of .10 points.
Experiment 1
Two visits were necessary to complete all measurements. Out of
90 individuals enrolled, 13 were excluded: 9 did not attend the
second visit, and in 4 subjects, TFO data could not be obtained
because of the limitations of the instrument. This left a ﬁnal study
population of 77 subjects: 26 non-CL wearers, 23 hydrogel lens
wearers, and 28 OK (Paragon-CRT) lens wearers. Participants in
the hydrogel group had been wearing hydrogel daily disposable
lenses for at least 3 years before the study outset. It was also
ensured that they wore their lenses at least 6 days per week and that
the hydrogel lenses were composed of the same material (60%
omaﬁlcon A). These participants were recruited among the patients
visiting the Optometry Clinic of the Complutense University. Non-
CL wearers were recruited among the undergraduates of the
optometry degree course of this university. The OK lens wearers
recruited were participants in a prior study conducted by our group
and had been wearing Paragon-CRT lenses also for at least 3
years.7,29 All subjects were whites.
Experiment 2
Of 40 white subjects enrolled through the Web page (http://
www.ucm.es/accion-social), 4 refused to participate and 5 with-
drew after starting OK treatment, leaving a ﬁnal population of 31
subjects. These subjects were divided into 2 groups matched for
age, refractive error, and corneal curvature (P.0.05) to be ﬁtted
with Paragon-CRT (n¼16) or Seefree (n¼15) OK lenses. Apart
from the visits for the initial assessment and TFO measurements,
these participants were required to attend standard visits for OK
lens ﬁtting. The 2 lens designs were HDS 100 Paragon-CRT (Par-
agon Vision Sciences; Interlenco, Madrid, Spain) and Seefree
made of Boston XO2 material (Conóptica, Barcelona, Spain). Both




The study followed a controlled protocol. All measurements
were made in the same ofﬁce. In the ﬁrst visit, clinical tests were
conducted in the same order by the same clinician for all subjects
enrolled: corneal topography, visual acuity (using Early Treatment
Diabetic Retinopathy Study logMAR charts), manifest refraction,
PRT, FBUT, and McMonnies questionnaire. Keratometric meas-
urements were performed with the Atlas 9000 topographer (Carl
Zeiss, Jena, Germany). Slitlamp examination included the assess-
ment of the ocular surface system (cornea, conjunctiva, eyelid, and
lid margin) to rule out anterior or posterior blepharitis, conjunc-
tivitis, and meibomian gland dysfunction or any abnormality that
could inﬂuence the results or contraindicate OK treatment.
Meibomian gland expressibility was checked by applying pressure
with the ﬁnger on the central tarsus of the lower lid. Corneal
integrity was conﬁrmed in a ﬂuorescein examination.
Tear Film Osmolarity Measurements
The TearLab Osmolarity System (TearLab) is easy to use as
suggested by Tomlinson et al30 and shows good agreement with
other instruments. According to the DEWS report,24 osmolarity is
considered among the most objective assessments of dry eye dis-
ease.31 We followed the measurement procedure described by
others.31 To ensure the system was working normally, we used
single-dose saline in every study visit before the measurements.
Three consecutive TFO readings were obtained for this purpose, as
suggested by Khanal and Millar and Tomlinson et al.32,33 After
taking TFO readings, the tear ﬁlm was examined by slitlamp
microscopy to rule out any adverse events that could affect out-
comes. In the OK groups, measurements were made in the morning
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2 to 4 hours after removing the lenses. In the soft CL wearers in
experiment 1, measurements were made within 2 to 4 hours of
waking without participants using their lenses. All subjects were
also asked to not use eyedrops.
Orthokeratology Lens Fitting
The following adaptation procedure for the lenses was
followed by a single CL practitioner according to the lens
manufacturers’ protocols: (1) lens speciﬁcations were determined
using the calculation rule (Paragon-CRT) or from the calculation
mode of the Oculus Easygraph (Oculus Optikgeraete GMBH)
(Seefree; Conóptica); (2) adequate ﬁtting was assessed using ﬂuo-
rescein; and (3) satisfactory ﬁtting was conﬁrmed by the typical
bull’s-eye pattern observed by corneal topography after an over-
night trial.
For lens ﬁtting, subjects were examined 1 day, 1 week, and 1
month after starting OK treatment. Subjects were instructed to
sleep about 8 hours with their OK lenses every night and to
clean them on a daily basis. All participants used MeniCare Plus
solution and a weekly protein remover (Menicon Progent;
Menicon, Co, Ltd, Nagoys, Japan). They were also supplied
with single doses of preservative-free lubricant eyedrops
(Moisture drops; Avizor, Madrid, Spain) for use before inserting
the lenses in their eyes every night and before lens removal
every morning. The use of the same lubricant was designed to
avoid possible composition effects on TFO. Benelli et al31 found
that some lubricant eyedrops reduced osmolarity more than
others after instillation.
Data Analysis
Statistical tests were performed using the STATGRAPHICS
package Centurion XVI, version 16.1.17. Only data obtained in
right eyes were used in this study. In both experiments, the TFO
data showed a Gaussian distribution according to the Kolmogorov-
Smirnov test. In Experiment 1, data between groups were
compared by one-way analysis of variance (ANOVA). In
Experiment 2, we compared TFO over time through repeated
measurements analysis and compared results between the groups
(Paragon-CRT, Seefree) using an unpaired-sample t test. To ana-
lyze TFO over time when both OK groups were combined, we
used 1-factor repeated measures analysis of variance. Signiﬁcance
was set at P,0.05.
RESULTS
In Table 1, we provide baseline means and standard deviations
for age, BCVA, refractive state, and corneal curvature measure-
ments for the right eyes of the participants of both experiments
(n¼77 and n¼31, respectively). None of the OK lens wearers who
completed the treatment experienced adverse effects related to lens
wear, and no abnormalities were detected by slitlamp microscopy
during the follow-up. Table 1 also provides baseline means and
standard deviations for the BUT, PRT, and McMonnies question-
naire results. None of the participants had DES according to diag-
nostic criteria established in Material and Method section.
Experiment 1
Values of TFO were within normal limits in all three groups
(Fig. 1). One-way analysis of variance identiﬁed signiﬁcant differ-
ences in TFO among groups (P,0.01; F¼28.10): higher TFO
values were observed in OK and hydrogel lens wearers than in
non-CL wearers (P,0.01) and values were higher in the OK group
than in hydrogel group (P,0.05).
Experiment 2
Mean sphere magnitudes and sphere equivalents decreased
signiﬁcantly during OK wear (P,0.00), whereas refractive
TABLE 1. Descriptive Variables Recorded in the 108 Study Participants at Baselinea
Group
Experiment 1 Experiment 2 (Data Obtained at Baseline)
Paragon-CRT, (n¼28) H CL, (n¼23) No CL, (n¼26)
ANOVA, P
Paragon-CRT, (n¼16) Seefree, (n¼15)
ANOVA, PMean6SD Mean6SD
Male/female, n 16/12 10/13 14/12 7/9 6/9
Age, yrs 23.663.1 22.861.8 23.661.6 0.39 23.961.6 24.261.2 0.61
SE, diopters 21.9061.00 22.3160.80 21.9060.92 0.22 22.1060.50 21.7660.96 0.12
Sim Kflat, diopters 43.5161.26 43.1961.50 43.2661.35 0.69 43.2161.40 43.5161.26 0.53
Sim Ksteep, diopters 44.1461.42 43.9261.56 44.0261.48 0.87 43.9461.46 44.1461.42 0.70
BCVA, logMAR 20.0660.06 20.1260.05 20.1060.06 ,0.01 20.1060.06 20.1260.05 0.22
FBUT, sec 9.662.10 9.5363.00 13.967.00 ,0.01 9.962.00 9.763.00 0.82
Phenol red test, mm 17.265.10 19.866.20 23.761.60 ,0.01 18.465.60 19.165.90 0.74
McMonnies Q 7.965 5.864 4.163 ,0.01 763 7.4763 0.67
aCL, contact lenses; FBUT, fluorescein breakup time; H, hydrogel; SD, standard deviation; SE, sphere equivalent; Sim Kflat and Sim Ksteep,
simulated corneal curvature readings for the flattest and steepest meridians; BCVA, best-corrected visual acuity; logMAR, logarithm of
the minimum angle of resolution; ANOVA, analysis of variance.
FIG. 1. Tear film osmolarity (in mOsm/L) values recorded in non–
contact lens wearers, hydrogel lens wearers, and orthokeratology
lens wearers (experiment 1). H¼hydrogel. Error bars indicate stan-
dard deviation at the 95% confidence level. Non–contact lens
wearers showed significantly lower tear film osmolarity values than
other two groups (analysis of variance, P¼0.0000; Levene post hoc P
values indicated in the figure).
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cylinder values remained unchanged in both the Paragon-CRT and
Seefree groups. Uncorrected visual acuity signiﬁcantly improved in
both OK groups (P,0.00). After 1 year of OK treatment, central
corneal power was signiﬁcantly reduced at both the steeper and
ﬂatter meridians (P,0.00) in the two groups. After discontinuation
of treatment, all measurements returned to baseline.
Measurements of TFO were within normal limits during follow-
up in both OK treatment groups. Means and standard deviations for
the TFO values recorded at each time point in both groups are
provided in Figure 2. Osmolarities differed signiﬁcantly at baseline
between the Paragon-CRT and Seefree groups (299.9612.7 vs.
288.569.5 mOsm/L; P¼0.02; F¼6.01; Fig. 2A). Through
repeated-measures analysis, signiﬁcant differences in TFO were
detected over time in the Paragon-CRT group, and TFO was sig-
niﬁcantly lower at the ﬁnal time point after lens wear cessation than
at the remaining time points (P,0.01; F¼4.75). Readings of TFO
were also reduced in the Seefree lens wearers in the ﬁnal follow-up
session, but the difference was not signiﬁcant (P.0.05; F¼1.81,
Fig. 2A). When the TFO data for both groups were combined (Fig.
2B), analysis of variance also revealed a signiﬁcant change in TFO
over time (P,0.01; F¼5.32), and the post hoc rank test identiﬁed
a signiﬁcant difference between the TFO value recorded 1 month
after OK lens discontinuation compared with the remaining time
points (baseline, I month, and 1 year) (Fig. 2B).
DISCUSSION
Orthokeratology is an effective reversible treatment that frees the
patient from the need for spectacles or CLs during waking hours.
Despite numerous investigations assessing the response of eyes to
this treatment, to the best of our knowledge, no study has addressed
the impact of OK lens wear on TFO. This study compares TFO
measurements in non-CL wearers and long-term (3 years or longer)
hydrogel and OK lens wearers. In addition, TFO changes produced
during long-term (1 year) OK treatment and the reversibility of
such changes after treatment cessation were assessed for the ﬁrst
time in young adults wearing two different OK lens designs.
In a meta-analysis, Tomlinson et al33 established normal TFO at
302 mOsmol/L (275–316 mOsmol/L) and the cutoff for tear ﬁlm
hyperosmolarity of the human cornea at 316 mOsmol/L. In our
study, all TFO measurements were within the normal limits. Low-
est and highest TFO values were found respectively in non-CL
wearers and OK lens wearers.
Although none of the TFO values recorded in our study could be
considered hyperosmotic, we observed signiﬁcantly higher osmo-
larities in CL wearers (hydrogel or OK) than non-CL wearers.
Thus, it is reasonable to assume that this higher TFO could be
attributed to CL wear.
These ﬁndings are in agreement with those of Sarac et al34 who
noted increased TFO in wearers of two different types of daily
disposable lenses (hydrogel and silicone hydrogel) over short peri-
ods. Osmolarities were similar to our values when measured before
CL insertion (293610.97 and 294613.66 mOsmol/L). Alghamdi
et al35 recently investigated the effects of the duration of soft CL
wear on the ocular surface system. Our measurements of TFO in
hydrogel CL wearers are consistent with those obtained in their
study for a similar period of CL wear. These authors observed no
effects on TFO based on the type of hydrogel lens worn, that is,
silicone hydrogel versus conventional hydrogel. However, their
TFO values in non-CL wearers were higher, and they observed
no signiﬁcant differences between non-CL wearers and soft CL
wearers as noted here. Given that the mean age of their non-CL
wearer group was similar to ours, this difference between the stud-
ies could be attributable to methodological discrepancies, such as
the time measurements were made (not speciﬁed in their study) or
the fact that we took three consecutive TFO readings. In our study,
wearing both CL types for at least 3 years raised TFO, although the
ﬁnal reading was lower than the cutoff for dry eye disease. Another
ﬁnding was that the OK lens group showed signiﬁcantly higher
TFO values than the hydrogel lens group. We attribute this differ-
ence to greater mechanical forces exerted by the overnight lenses
on the anterior corneal surface especially considering that measure-
ments were taken in the morning when the tear ﬁlm is more unsta-
ble because of these forces. Choy et al16 reported effects on tear
composition, such as marked elevations in albumin and lactate
dehydrogenase, indicating hypoxic stress to the eye surface during
overnight OK lens wear. In addition, Gonzalez-Perez et al17
observed increased levels of inﬂammatory markers in subjects
wearing OK lenses compared with the continuous wear of silicone
hydrogel lens in the long term. This response could be explained
FIG. 2. Changes in tear film osmolarity (mOsm/L) recorded during the 13-month orthokeratology (OK)
trial (experiment 2). (A) Values of tear film osmolarity (TFO) plotted over time for the Paragon-CRT versus
Seefree group. Unbroken line indicates Paragon-CRT group (analysis of variance; P¼0.005). Values of TFO
were significantly lower at 1 month without OK versus all the other time points. Broken line indicates
Seefree group (analysis of variance, P¼0.1644). Analysis of variance, Paragon-CRT versus Seefree at
baseline (P¼0.022). (B) Mean TFO values plotted over time for the Paragon-CRT and Seefree groups
combined. Error bars indicate standard deviation at the 95% confidence level. M, month, w/o OK, after
interruption of OK treatment. P¼0.019, analysis of variance. Values of TFO were significantly lower at 1
month without OK versus all the other time points (P,0.05 for each of the 3 comparisons).
A. Nieto-Bona et al. Eye & Contact Lens  Volume 0, Number 0, Month 2016
4 Eye & Contact Lens  Volume 0, Number 0, Month 2016
Copyright  Contact Lens Association of Opthalmologists, Inc. Unauthorized reproduction of this article is prohibited.
by the physical impact of treatment on the corneal epithelium.
According to Liu et al,36 the corneal epithelium reacts to hyper-
osmolar stress, and this may occur in areas where the tear ﬁlm is
more unstable, like local thinner areas, as in OK wearers. However,
the slightly higher TFO detected here in the OK lens wearers
compared with the subjects who habitually wore hydrogel is not
likely to produce any negative effects. The DEWS25,37 reported
that an elevated TFO is one of the key pathological factors in
dry eye, leading to ocular discomfort associated with damage to
the ocular surface and inﬂammation. In contrast, Carracedo et al21
noted that OK treatment did not produce symptoms of ocular dry-
ness, possibly because their OK subjects who did not wear CL
during the day were compared with wearers of rigid gas-
permeable CL who reported symptoms of discomfort. The lack
of a daytime wearing regimen could thus be a beneﬁt for OK lens
wearers in that discomfort arising from hyperosmolarity is avoided.
In effect, Liu et al36 suggested that blinking and reﬂex secretion of
tears should serve to mitigate prolonged local hyperosmotic con-
ditions, as probably happens in OK wearers throughout the day. It
would be interesting to conﬁrm this notion in OK patients. Other
studies have shown an interrelationship between SBNP density and
corneal sensitivity. Nieto-Bona et al7 reported reduced SBNP nerve
densities in response to OK treatment. Lum et al12 also described
SBNP nerve ﬁber redistribution in OK lens wearers, whereas Lin-
na38 directly correlated subbasal nerve morphology changes with
corneal sensitivity in patients who had undergone laser in situ
keratomileusis surgery. Nerve injury has been shown to reduce
corneal sensitivity, which in turn increases TFO.25 This could
explain the higher TFO values recorded in our OK group. Corre-
lating these three variables would be another interesting topic for
future studies.
In the second experiment of our study, we compared TFO values
between two groups of subjects (all prior CL wearers) ﬁtted with
different OK lens designs over time. Unexpectedly, these two
groups differed signiﬁcantly in terms of TFO at baseline, with the
Paragon-CRT group showing the higher mean value. When trying
to ﬁnd an explanation for this difference, we noted similar
distributions of means and standard deviations and similar trends
in this variable over time in the two groups. Therefore, we propose
two possible explanations: (1) the wash-out period was not long
enough or (2) the subjects failed to comply with the stipulated
wash-out period. We believe that this second factor was the main
reason for the higher osmolarity observed in the Paragon-CRT
group at baseline. In addition, when changes in TFO were
examined over time, the greater decrease observed at the ﬁnal
time point in the Paragon-CRT group was likely attributable to the
greater starting value (P,0.01; F¼4.75). We propose that the sub-
jects in this group did not adhere as much to the 4-week wash-out
period, explaining their higher baseline TFO value. Because of this
situation, when approaching the end of the treatment period, we
purposely stressed the importance of complying with the 1-month
period of non-OK lens wear for the ﬁnal TFO readings. Another
remarkable ﬁnding was that TFO did not signiﬁcantly increase
during OK lens wear, and only slight ﬂuctuations were observed
over the year of treatment. In a clinical assessment of the Oculo-
Sense Tear Lab instrument, Eperjesi et al39 argued that the differ-
ence in measurements that could be considered clinically relevant
for healthy subjects is 33 mOsmol/L. This difference is far from the
trend observed here. Our data indicate a signiﬁcant decrease in
TFO during OK lens wear and that recovered TFO values after 1
month of OK treatment cessation were similar to the TFO readings
obtained in the non-CL wearers of experiment 1. This suggests that
the wash-out period was long enough and that the higher osmolar-
ities observed at baseline in one of the OK treatment groups in
experiment 2 could reﬂect TFO variability among subjects, a lack
of compliance regarding the wash-out period before treatment, or
the limitation of the measurement method. We should nevertheless
underscore that all TFO values obtained here were within the nor-
mal limits for healthy corneas.
Thus, it seems that the presence of proinﬂammatory markers in
the tear ﬁlm, as reported by Gonzalez-Perez et al17 for a similar
treatment period, does not raise TFO values beyond normal limits.
It would be interesting to address the proinﬂammatory marker
response in parallel with corneal epithelial and SBNP responses
in the long term.
As far as we are aware, the present study is the ﬁrst to determine
TFO values during hydrogel and OK lens wear in young adults
with special attention paid to the impacts on this variable of long-
term OK treatment and the reversibility of these impacts after
treatment cessation. In conclusion, our ﬁndings indicate that long-
term hydrogel and OK lens wear leads to increased TFO values
compared with non-CL (spectacle) wear, although the values
observed here were still within the normal limits. In addition,
TFO remained stable over 1 year of OK treatment, and by 1 month
after treatment interruption, TFO had returned to lower than
baseline levels. These low TFO levels were effectively comparable
to the osmolarities observed in non-CL wearers and suggest the full
reversibility of the corneal response to OK treatment.
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